scholarly journals Clinical outcomes and patients’ perceptions of nurse-led healthy lifestyle clinics

2011 ◽  
Vol 3 (1) ◽  
pp. 48 ◽  
Author(s):  
Bob Marshall ◽  
Sue Floyd ◽  
Rachel Forrest
Keyword(s):  
Patient Satisfaction ◽  
Clinical Outcome ◽  
Clinical Outcomes ◽  
Healthy Lifestyle ◽  
Treatment Plan ◽  
Target Population ◽  
Outcome Data ◽  
Health Needs ◽  
Average Weight ◽  
Clinical Outcome Data

BACKGROUND AND CONTEXT: The Nurse-Led Healthy Lifestyle Clinics focussed on lifestyle issues for patients with known health inequalities. Much of the nursing was educative and preventative care. This evaluation assessed patient experiences and opinions, as well as clinical outcomes. ASSESSMENT OF PROBLEM: Information came from clinical outcome data for 2850 individuals and 424 patient satisfaction surveys. Results: Patients were aged 0–95 years (45% between 40 and 59 years); 60% Pakeha/European, 31.4% Maori, 4.2% Pacific and 4.4% other ethnicities. Only 19% of claimants (approximately 40% were Maori or Pacific) came from quintile 5 addresses, suggesting the target population was not reached effectively. Ninety-four percent of patients had a better understanding of their diagnosis, medication and treatment plan, and were more motivated to self-manage their health needs. This increase in patient empowerment is a significant outcome of the project. Clinical outcome data showed no significant differences between first and last clinic visits for average weight, blood pressure, smoking, glycosylated haemoglobin levels, waist circumference or cardiovascular risk. Significant improvements were shown in the Dartmouth Primary Care Cooperative Information results for social activity, change in health, and overall health (n=89). STRATEGIES FOR IMPROVEMENT: More effective techniques to access the target population have been implemented, as has an extended period for review of clinical outcomes. LESSONS: More focussed evaluation of clinical outcomes is necessary to provide quantitative data on the clinics. The large percentage of patients who felt more empowered to self-manage their health needs suggests the clinics were effective in this area. KEYWORDS: Nurse-led clinics; life style; program evaluation; patient satisfaction; health status disparities

P–574 Examination of inter centre variation in PGT-A “no result rate” and efficacy of rebiopsy - Analysis of 22,833 samples 2015–2019

2021 ◽  
Vol 36 (Supplement_1) ◽  
Author(s):  
C Lynch ◽  
K Sanders ◽  
T Gordon ◽  
D Griffin
Keyword(s):  
Clinical Outcome ◽  
Clinical Outcomes ◽  
Outcome Data ◽  
Exact Test ◽  
Clinical Outcome Data ◽  
Wide Range ◽  
Impact On Survival ◽  
Registration Number ◽  
Patient Use

Abstract Study question Are there significant differences in PGT-A “no result” rates and clinical outcomes following rebiopsy between ART clinics, and do rebiopsied embryos perform better than transferring with no result? Summary answer There is significant differences between clinics in terms of “no result rate” in PGT-A and utilisation of rebiopsy. What is known already: With any testing platform used in PGT-A, there is always a chance that a sample will not yield a result and rebiopsy may be considered to ascertain an embryos cytogenetic status. Studies have demonstrated rebiopsy yields results and adds to embryos genetically suitable for transfer. Clinical outcome data, however, remains scarce, leading to difficulty for clinics in benchmarking their performance when rebiopsied embryos are transferred. Study design, size, duration A retrospective analysis was performed of trophectoderm samples submitted for PGT-A via NGS over a 5yr period, 2015–2019. The no result (NR) rate was calculated per year and per clinic. Clinics were contacted for follow up data on NR embryos in terms of usage and clinical outcomes. Clinical outcomes from rebiopsied embryos were compared with those transferred as NR without rebiopsy. Participants/materials, setting, methods Data was collected on 22833 trophectoderm samples, submitted by 30 IVF laboratories. NR rate was analysed by year and by clinic. Clinics were asked if NR embryos had undergone rebiopsy, and if so if they had survived warming and rebiopsy. Clinics were asked if embryos selected for transfer had survived (re)warming, and to provide clinical follow-up including hCG test, clinical pregnancies, miscarriage and livebirth. The two tailed Fishers exact test was used for statistical analysis. Main results and the role of chance There was a wide range in sample numbers submitted by clinics over the time period, ranging from 9 samples through to 2633. In tclinics submitting over 500 samples the NR rate ranged from 0.6% to 7.4%, and in the those submitting 100–499 samples it ranged from 1.1% to 5.8%. Both these differences proved to be statistically significant (p < 0.05) between the best and worst performing clinics, and shows that a gap in performance exists between clinics. Less than 50% of NR embryos underwent rebiopsy. While the majority of embryos undergoing rebiopsy yielded a result (92.3%) and 31.4% of these were euploid or mosaic, almost half still remain in storage. The rate of livebirth/ongoing implantation in the rebiopsy group is 35.5% and 17.1% in the non rebiopsy group, illustrating a non significant trend towards a higher chance of implantation and livebirth in the rebiopsy group. Of 58 patients undergoing rebiopsy without any euploids in their initial cycle, 18 had a euploid embryo identified for future use. The additional manipulations involved in rebiopsy do not impact on survival at warming for transfer, but clinical outcomes in rebiopsied embryos appear poorer than those where a result was generated at first biopsy. Limitations, reasons for caution Despite starting with 22833 samples, 1115 of which were classified as NR, there were only 31 rebiopsied and 42 NR embryos transferred. It was therefore not possible to analyse transfer data by clinic or by embryo quality. Wider implications of the findings: Rebiopsy yields genetic results and embryos suitable for patient use, including for patients who produced no other euploid/mosaic embryos in their cycle. However, it is not offered/performed in many cases. Clinical outcome data must continue to be compiled and analysed to confirm performance exceeds transfer of NR embryos. Trial registration number Not applicable

Effect of Manipulation under Anesthesia of the First Knee in Staged Bilateral Total Knee Arthroplasty on Clinical Outcome and Satisfaction

2020 ◽  
Author(s):  
Jung-Won Lim ◽  
Yong-Beom Park ◽  
Dong-Hoon Lee ◽  
Han-Jun Lee
Keyword(s):  
Total Knee Arthroplasty ◽  
Patient Satisfaction ◽  
Clinical Outcome ◽  
Clinical Outcomes ◽  
Knee Arthroplasty ◽  
Knee Flexion ◽  
Functional Score ◽  
Manipulation Under Anesthesia ◽  
Total Knee

AbstractThis study aimed to evaluate whether manipulation under anesthesia (MUA) affect clinical outcome including range of motion (ROM) and patient satisfaction after total knee arthroplasty (TKA). It is hypothesized that MUA improves clinical outcomes and patient satisfaction after primary TKA. This retrospective study analyzed 97 patients who underwent staged bilateral primary TKA. MUA of knee flexion more than 120 degrees was performed a week after index surgery just before operation of the opposite site. The first knees with MUA were classified as the MUA group and the second knees without MUA as the control group. ROM, Knee Society Knee Score, Knee Society Functional Score, Western Ontario and McMaster Universities (WOMAC) score, and patient satisfaction were assessed. Postoperative flexion was significantly greater in the MUA group during 6 months follow-up (6 weeks: 111.6 vs. 99.8 degrees, p < 0.001; 3 months: 115.9 vs. 110.2 degrees, p = 0.001; 6 months: 120.2 vs. 117.0 degrees, p = 0.019). Clinical outcomes also showed similar results with knee flexion during 2 years follow-up. Patient satisfaction was significantly high in the MUA group during 12 months (3 months: 80.2 vs. 71.5, p < 0.001; 6 months: 85.8 vs. 79.8, p < 0.001; 12 months: 86.1 vs. 83.9, p < 0.001; 24 months: 86.6 vs. 85.5, p = 0.013). MUA yielded improvement of clinical outcomes including ROM, and patient satisfaction, especially in the early period after TKA. MUA in the first knee could be taken into account to obtain early recovery and to improve patient satisfaction in staged bilateral TKA.

Increasing engagement with clinical outcome data

2011 ◽  
Vol 17 (12) ◽  
pp. 585-589
Author(s):  
Riaz Dharamshi ◽  
Toby Hillman ◽  
Rory Shaw
Keyword(s):  
Clinical Outcome ◽  
Outcome Data ◽  
Clinical Outcome Data

scholarly journals Association between duration of untreated bipolar disorder and clinical outcome: data from a Brazilian sample

2016 ◽  
Vol 38 (1) ◽  
pp. 6-10 ◽  
Author(s):  
Gustavo C. Medeiros ◽  
Sofia B. Senço ◽  
Beny Lafer ◽  
Karla M. Almeida
Keyword(s):  
Bipolar Disorder ◽  
Clinical Outcome ◽  
Outcome Data ◽  
Brazilian Sample ◽  
Clinical Outcome Data

scholarly journals Establishment and Use of Epidemiological Cutoff Values for Molds and Yeasts by Use of the Clinical and Laboratory Standards Institute M57 Standard

2017 ◽  
Vol 55 (5) ◽  
pp. 1262-1268 ◽  
Author(s):  
Shawn R. Lockhart ◽  
Mahmoud A. Ghannoum ◽  
Barbara D. Alexander
Keyword(s):  
Clinical Practice ◽  
Clinical Outcome ◽  
Antifungal Agent ◽  
Outcome Data ◽  
Fungal Isolate ◽  
Wild Type ◽  
Clinical Outcome Data ◽  
Cutoff Values

ABSTRACT Breakpoints are used to predict whether an antifungal agent will be clinically effective against a particular fungal isolate. They are based on a combination of MIC values, pharmacokinetic/pharmacodynamic values, and clinical outcome data. For many fungus-antifungal combinations, these data might never be available. For these combinations, epidemiological cutoff values (ECVs) provide a methodology for categorizing isolates as either wild type (WT) or non-WT. In this review, we define ECVs, explain how they are generated using the CLSI methodology in standard M57, and describe how they can be used in clinical practice.

scholarly journals Thrombolytic-Related Asymptomatic Hemorrhagic Transformation Does Not Deteriorate Clinical Outcome: Data from TIMS in China

PLoS ONE ◽  
2015 ◽  
Vol 10 (11) ◽  
pp. e0142381 ◽  
Author(s):  
Weihua Jia ◽  
Xiaoling Liao ◽  
Yuesong Pan ◽  
Yilong Wang ◽  
Tao Cui ◽  
...  
Keyword(s):  
Clinical Outcome ◽  
Hemorrhagic Transformation ◽  
Outcome Data ◽  
Clinical Outcome Data

WE-D-T-6E-07: Incorporating Clinical Outcome Data Into IMRT Inverse Planning

2005 ◽  
Vol 32 (6Part19) ◽  
pp. 2140-2140
Author(s):  
L Xing ◽  
Y Yang ◽  
B Widrow
Keyword(s):  
Clinical Outcome ◽  
Outcome Data ◽  
Inverse Planning ◽  
Clinical Outcome Data
Sign in / Sign up

Export Citation Format

Share Document